Controversies in Stroke CareAcute Interventions
Original Event: Feb. 28, 2013 |
The Program
Significant knowledge and practice gaps exist across the continuum of stroke care. Stroke is highly preventable, yet nearly 800,000 strokes occur each year. Although effective treatments exist that could benefit up to 40 percent of stroke patients, fewer than 10 percent of stroke patients actually receive these treatments.
Controversy is a hallmark of new ideas in medicine. As an education strategy, the identification and exploration of controversial topics enables an effective debate about unresolved issues, resulting in greater consensus supported by evidence-based medicine and expert opinion.
This webinar will include discussions of criteria used to assess intervention decisions and the reaction to three reviews of acute intervention studies and trials presented at the 2013 International Stroke Conference.
Target Audience
The target audience for this activity includes neurologists, neuroscience nurses, emergency department physicians and nurses, hospitalists and others involved in the acute treatment of stroke patients.
Program Goals
To increase healthcare professionals’ knowledge of the controversies surrounding interventional treatments in acute stroke patients. This webinar will include the following intervention topics:
- Utilize evidence based and professional practice based knowledge to make decisions about acute stroke interventions
- Apply evidence-based knowledge of neurothrombectomy devices when making treatment decisions for acute stroke patients
- Interpret controversies between evidence-based practice and clinical utility for acute stroke treatment
Physician Accreditation
This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of Medical Education Resources (MER) and National Stroke Association. MER is accredited by the ACCME to provide continuing medical education for physicians.
Credit Designation
Medical Education Resources designates this enduring material for a maximum of 1 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing Accreditation
Medical Education Resources is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.
This CE activity provides 1 contact hour of continuing nursing education.
Provider approved by the California Board of Registered Nursing, Provider Number 12299 for 1 contact hour.Method of Participation
This enduring webinar is designed for individual viewing. The post-test and evaluation are electronic and can only be completed by an individual after watching the program. There are no fees for participating in and receiving credit for this activity.
During the period from Feb. 28, 2013, through March 14, 2014, participants must 1) read the learning objectives and faculty disclosures, 2) study the educational activity, 3) complete the post-test by recording the best answer to each question, 4) complete the evaluation form and 5) click on “Submit” to return to National Stroke Association.
If you are viewing this program in a group, contact Valerie Siebert-Thomas at vsiebert-thomas@stroke.org for more information.
Faculty
Mark J. Alberts, MD
Professor of Neurology
University of Texas Southwestern Medical Center at Dallas
Dallas, Texas
Robert Ferguson, MD
Chair of Radiology
MetroHealth
Cleveland, Ohio
Richard Latchaw, MD
Professor of Radiology
UC Davis Medical Center
Sacramento, Calif.
Disclosure of Conflicts of Interest
Medical Education Resources ensures balance, independence, objectivity and scientific rigor in all its educational activities. In accordance with this policy, MER identifies conflicts of interest with its instructors, content managers and other individuals who are in a position to control the content of an activity. Conflicts are resolved by Medical Education Resources to ensure that all scientific research referred to, reported or used in a CME activity conforms to the generally accepted standards of experimental design, data collection and analysis. MER is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not the business interest of a commercial interest.
Faculty Disclosures
The faculty
reported the following financial relationships with commercial interests whose
products or
services may be mentioned in this CME activity:
Dr.
Mark Alberts is a speaker/consultant for Genentech, Inc.
Dr. Robert Ferguson has no financial
relationships to disclose.
Dr.
Richard Latchaw has 5 percent ownership of NexGen Medical Systems, Inc. and three
patents for endovascular devices.
The content managers reported the following financial relationships with commercial interests whose products or services may be mentioned in this CME activity:
Denise Henasey, National
Stroke Association, has no financial relationships to disclose.
Julie Johnson,
PharmD, MER, has no financial relationships to disclose.
Veronda Smith, FNP-BC, MER, has no financial
relationships to disclose.
Disclaimer
The content and views presented in this educational activity are those of the authors and do not necessarily reflect those of MER, National Stroke Association, Genentech and/or Penumbra Inc. The authors have disclosed if there is any discussion of published and/or investigational uses of agents that are not indicated by the FDA in their presentations. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of MER, National Stroke Association, Genentech and/or Penumbra Inc. MER’s ANCC accreditation status does not imply endorsement by MER or ANCC of any commercial products displayed in conjunction with this activity. Before prescribing any medicine, primary references and full prescribing information should be consulted. Any procedures, medications or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patients’ conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information and comparison with recommendations of other authorities. The information presented in this activity is not meant to serve as a guideline for patient management.
System
requirements:
PC-based attendees—Required: Windows® 2000, XP Home, XP Pro, 2003 Server, Vista
or newer.
Macintosh®-based attendees—Required: Mac OS X 10.4 (Tiger®) or newer.
To view MER’s Privacy Policy: http://www.mer.org/privacy_policy
Controversies in Stroke Care Webinar Series
 |
Redefining Inclusion/Exclusion Criteria for IV tPA Use |
|
Rehabilitation for Stroke Patients |
|
Acute Interventions |
The Controversies in Stroke Care webinar series is brought to you by an educational grant from Genentech, Inc. and Penumbra, Inc.
